6846 fundamentals
An in-depth look to GREENYN BIOTECHNOLOGY CO LTD operating, investing, and financing activities
6846 free cash flow for Q4 24 is 86.21 M TWD. For 2024, 6846 free cash flow was 210.99 M TWD and operating cash flow was 219.66 M TWD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM